Related Experiment Video
Updated: Feb 12, 2026
08:24
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
7.5K
What can we do to optimize stem and progenitor cell therapy for heart failure?
Xiaolong Song1,2, Huiyan Qu1, Yong Wang1
1Department of Cardiology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Discovery Medicine
|April 12, 2018
Summary
Optimizing stem cell therapy is crucial for treating heart failure. This review explores "seeds" like cell types and "fertilizers" such as genetic strategies to enhance stem cell efficacy for cardiac repair.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Stem cells offer potential for heart failure treatment by regenerating cardiac tissue.
- Current stem cell therapies face challenges including poor cell survival, integration, homing, and differentiation.
- Optimizing stem cell therapy is essential to overcome these limitations and improve clinical outcomes.
Purpose of the Study:
- To provide a comprehensive review of strategies for optimizing stem cell therapy for heart failure.
- To discuss critical factors influencing stem cell efficacy in cardiac repair.
- To highlight the need for enhanced approaches in stem cell transplantation for heart failure.
Main Methods:
- Review of existing literature on stem cell types and their characteristics (age, dose, combinations).
- Analysis of methods to optimize stem/progenitor cells, including genetic modification and preconditioning.
- Exploration of physical modifications and combination therapies to improve cell engraftment and function.
Main Results:
- Identified key parameters for selecting optimal stem cell 'seeds' (e.g., cell type, dose, age).
- Detailed various 'fertilizer' strategies to enhance stem cell survival, integration, and cardiac differentiation.
- Highlighted the importance of a multi-faceted approach combining cell selection and optimization techniques.
Conclusions:
- Effective stem cell therapy for heart failure requires careful selection of cell 'seeds' and optimization using 'fertilizer' strategies.
- Addressing challenges in cell viability, homing, and engraftment is critical for successful cardiac regeneration.
- Further research into optimizing stem cell parameters and delivery methods will advance clinical applications for heart failure.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:27Heart Failure I: Introduction
951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
01:30Heart Failure V: Medical Management
360
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360